Diagnostic News and Research

RSS

Biomedical Systems selects Global 360's Process360 BPM suite for improving report, image communication

Global 360, a leading provider of Process and Document Management solutions, today announced that Biomedical Systems, a global leader in centralized diagnostic testing for the pharmaceutical and medical device industry, has chosen Global 360 to improve how critical reports and images are communicated and reported to its customers. In the process, the company will also save thousands on courier costs, satisfy a "going green" initiative, and mitigate risk, helping satisfy auditors and regulators.

12 Apr 2010

EDNOS categorization for young people needs to be reconsidered

Diagnostic cutoffs for anorexia nervosa and bulimia nervosa may be too strict, a study from the Stanford University School of Medicine and Lucile Packard Children's Hospital has found. Many patients who do not meet full criteria for these diseases are nevertheless quite ill, and the diagnosis they now receive, "Eating Disorder Not Otherwise Specified," may delay their ability to get treatment.

12 Apr 2010

Rosetta Genomics to present posters on microRNA-based technologies at AACR 2010

Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostic tests, announced today it will present multiple posters at the upcoming American Association of Cancer Research's 101st Annual Meeting to be held at the Walter E. Washington Convention Center in Washington, D.C. from April 17-21, 2010.

12 Apr 2010

New CZT-based cardiac nuclear imaging system now at Mount Sinai Medical Center

The Mount Sinai Medical Center has become the first in the United States to commercially use a new cardiac nuclear imaging system by GE Healthcare, a cadmium zinc telluride (CZT)-based high-speed, high-resolution camera that drastically reduces imaging time for patients while also reducing radiation exposure compared to previously used technologies.

12 Apr 2010

Study shows promising basis for development of effective liver-cancer screening test

Liver cancer is the fifth most common cancer in the world and one of the deadliest cancers since it is rarely diagnosed until late in its development.

12 Apr 2010

FDA issues complete response letter regarding the NDA for OMAPRO

ChemGenex Pharmaceuticals announces that the U.S. Food and Drug Administration's Office of Oncology Drug Products has issued a complete response letter regarding the new drug application for OMAPRO for the treatment of adults with chronic myeloid leukemia who have failed prior therapy with imatinib and have the Bcr-Abl T315I mutation.

12 Apr 2010

Investment report on Radient Pharmaceuticals from StockPreacher.com

StockPreacher.com announces an investment report featuring Radient Pharmaceuticals Corp. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

9 Apr 2010

Drugs that affect methylation state of genes could reverse autism's effects: The FASEB Journal

A new discovery raises hope that autism may be more easily diagnosed and that its effects may be more reversible than previously thought. In a new study appearing online in The FASEB Journal, scientists have identified a way to detect the disorder using blood and have discovered that drugs which affect the methylation state of genes could reverse autism's effects.

9 Apr 2010

World's largest autism science and advocacy organization awards 16 new research grants

Autism Speaks, the world's largest autism science and advocacy organization, today announced the awarding of 16 new research grants totaling $5,223,743 over the next three years.

9 Apr 2010

Researchers make dramatic strides in understanding and treating leukemia

In the past decade, researchers have made dramatic strides in understanding and treating leukemia, according to the April issue of Mayo Clinic Health Letter.

9 Apr 2010

Merge Healthcare to exhibit expanded suite of women's imaging solutions at NCBC 2010

Merge Healthcare, a health IT solutions leader, today announced it will be showcasing it's expanded suite of innovative solutions and support of comprehensive continuing education programs for the advancement of women's imaging at the National Conference on Breast Cancer (NCBC) 2010. Additionally, Merge plans to introduce and collaborate with attendees on its Women's Healthcare Initiative, which builds partnerships with clinicians to provide broader access to training in the analysis and interpretation of these important studies.

8 Apr 2010

LSDF announces $15M in program grant to enhance diagnosis and treatment of cancer

The Life Sciences Discovery Fund today announced nearly $15 million in program grant awards to support collaborative research initiatives spearheaded by three Washington state life sciences organizations.

8 Apr 2010

Roche NimbleGen to implement GMP for DNA microarrays suite

Roche NimbleGen, announced today a company-wide initiative to implement Good Manufacturing Processes (GMP) for its suite of DNA microarrays. The implementation of GMP will cover the full scope of processes from development through manufacturing and will include all locations. The company plans on achieving GMP compliance followed by subsequent submission for clearance or approval of select array products to the US Food and Drug Administration.

8 Apr 2010

Biocartis closes Series 'B' equity financing round

Biocartis SA, a biotech company active in the field of personalized medicine and focused on fast, multiplexed and fully integrated molecular diagnostics based on its proprietary micro-technology and sample preparation platforms, today announced the successful closing of a Series B equity financing round. The Company raised EUR 30 million (~ USD 41.3 million) from its current shareholder base of leading life science investors and two new strategic investors from the pharmaceutical/diagnostic industry.

From Biocartis 8 Apr 2010

Consumer engagement program for diagnostic imaging services

More consumers than ever before are seeking additional knowledge to make more informed decisions, especially when it comes to their health care.

8 Apr 2010

Unique collaboration in fetal medicine among Columbus' healthcare professionals

The Columbus Fetal Medicine Collaborative has been formed by Mount Carmel Health System, OhioHealth, The Ohio State University Medical Center and Nationwide Children's Hospital joining together to provide optimal outcomes for high-risk expectant mothers and their babies with suspected fetal abnormalities.

8 Apr 2010

Debiopharm Group, Biocartis sign investment agreement

Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and which has embarked in the field of companion diagnostics with a view to progressing in the area of personalized medicine, today announced the signature of an investment agreement with Biocartis.

8 Apr 2010

Pair of proteins excreted in urine could lead to earlier diagnosis of kidney cancer: Researchers

Studying patients with kidney cancer, a team of researchers at Washington University School of Medicine in St. Louis has identified a pair of proteins excreted in the urine that could lead to earlier and more accurate diagnosis of the disease.

8 Apr 2010

The $560 million for cancer centers not enough says Cancer Council

The Federal Government has announced a $560 million for new or upgraded cancer centres across Australia this week. The Cancer Council of Australia while welcoming this gesture has said that this is not the complete solution when it comes to helping regional and rural patients of Australia. This statement was made by the CEO Ian Olver who said that this “unprecedented” amount of money can go a long way to help but more support is needed. One of the regional cancer support networks has gone further to criticize the fact that so much is doled out in patient accommodation instead of advanced cancer treatment and care services.

8 Apr 2010

EndoChoice announces acquisition of Pathworks Anatomic Pathology Laboratory

EndoChoice, Inc. announced today that it has acquired Pathworks Anatomic Pathology Laboratory. Founded in 1989, Pathworks is a College of American Pathologists (CAP) accredited national reference laboratory located in Atlanta, GA. Robert Smith, MD, founder of the laboratory, will assume the Medical Director position of EndoChoice Pathology, a wholly-owned subsidiary of EndoChoice, Inc.

8 Apr 2010